UNLIMITED FREE
ACCESS TO THE WORLD'S BEST IDEAS

SUBMIT
Already a GlobalSpec user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your GlobalSpec Experience

Select Your Free Newsletters

Industry Newsletters

Select Your Free Product Alerts

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

BSI - BS ISO 13019

Tissue-engineered medical products — Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

active, Most Current
Buy Now
Organization: BSI
Publication Date: 30 June 2018
Status: active
Page Count: 24
ICS Code (Implants for surgery, prosthetics and orthotics): 11.040.40

Document History

BS ISO 13019
June 30, 2018
Tissue-engineered medical products — Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis
A description is not available for this item.

References

This document references:
ISO 13022 - Medical products containing viable human cells - Application of risk management and requirements for processing practices
Published by ISO on April 1, 2012
This International Standard specifies requirements and guidance for processing practices and managing risk associated with viable cellular components of products regulated as medicinal products,...
This document references:
ISO TS 10993-19 - Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials
Published by ISO on March 1, 2020
This document provides a compilation of parameters and test methods that can be useful for the identification and evaluation of the physical, i.e. physico‑chemical, morphological and topographical...
This document references:
ISO 12891-1 - Retrieval and analysis of surgical implants - Part 1: Retrieval and handling
Published by ISO on July 1, 2015
This part of ISO 12891 specifies the method to be followed for the retrieval and handling of surgical implants and associated tissues and fluids. In particular, it specifies the essential steps to be...
This document references:
ISO 13022 - Medical products containing viable human cells - Application of risk management and requirements for processing practices
Published by ISO on April 1, 2012
This International Standard specifies requirements and guidance for processing practices and managing risk associated with viable cellular components of products regulated as medicinal products,...
This document references:
ISO 12891-1 - Retrieval and analysis of surgical implants - Part 1: Retrieval and handling
Published by ISO on July 1, 2015
This part of ISO 12891 specifies the method to be followed for the retrieval and handling of surgical implants and associated tissues and fluids. In particular, it specifies the essential steps to be...
This document references:
ISO TS 10993-19 - Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials
Published by ISO on March 1, 2020
This document provides a compilation of parameters and test methods that can be useful for the identification and evaluation of the physical, i.e. physico‑chemical, morphological and topographical...
View Less
View All
Advertisement